Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

19.24

-0.02 (-0.10%)

At close: Mar 24, 2026, 4:00 PM EDT

19.54

+0.30 (1.56%)

Pre-market: Mar 25, 2026, 7:07 AM EDT

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Mar '26 Mar 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	5,436	7,623	-	-	-
Enterprise Value	5,065	7,201	0	0	0
Last Close Price	19.24	26.98	-	-	-
PE Ratio	-	-8.38	-	-	-
PS Ratio	6.69	9.39	-	-	-
PB Ratio	9.42	2.44	-	-	-
P/TBV Ratio	1.03	1.44	-	-	-
P/FCF Ratio	81.26	113.95	-	-	-
P/OCF Ratio	65.37	91.67	-	-	-
EV/Sales Ratio	6.24	8.87	-	-	-
EV/EBITDA Ratio	74.78	106.33	-	-	-
EV/EBIT Ratio	112.27	159.63	-	-	-
EV/FCF Ratio	75.71	107.65	-	-	-
Debt / Equity Ratio	0.12	0.12	-1.15	-8.46	0.67
Debt / EBITDA Ratio	-46.14	5.60	-1.82	-0.62	-0.83
Debt / FCF Ratio	5.67	5.67	-1.50	-0.56	-0.68
Net Debt / Equity Ratio	-0.13	-0.13	-0.12	-0.02	0.11
Net Debt / EBITDA Ratio	51.27	-6.22	-1.50	-0.15	0.72
Net Debt / FCF Ratio	-6.29	-6.29	-1.23	-0.14	0.58
Asset Turnover	1.11	1.11	1.09	0.54	0.36
Inventory Turnover	7.94	5.29	5.27	4.52	3.80
Quick Ratio	7.17	7.17	0.94	1.90	3.31
Current Ratio	7.85	7.85	1.30	2.55	3.77
Return on Equity (ROE)	-17.03%	-4.78%	189.92%	-293.83%	-127.28%
Return on Assets (ROA)	-4.20%	6.14%	-67.96%	-56.54%	-44.01%
Return on Invested Capital (ROIC)	-16.69%	24.43%	-141.47%	-154.94%	-143.70%
Return on Capital Employed (ROCE)	-5.24%	7.67%	-103.66%	-71.15%	-54.39%
Earnings Yield	-9.90%	-11.93%	-	-	-
FCF Yield	1.23%	0.88%	-	-	-
Buyback Yield / Dilution	-6.79%	-6.79%	-	-	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q